Cingulate Inc. (CING)

NASDAQ: CING · Real-Time Price · USD

4.050

-0.050 (-1.22%)

At close: Jun 27, 2025, 4:00 PM

4.060

+0.010 (0.25%)

After-hours: Jun 27, 2025, 7:58 PM EDT

Cingulate Employees

Cingulate had 13 employees as of December 31, 2024. The number of employees did not change compared to the previous year.

Employees

13

Change (1Y)

n/a

Growth (1Y)

n/a

Revenue / Employee

n/a

Profits / Employee

-$1,259,689

Market Cap

17.20M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	13	0	-
Dec 31, 2023	13	-2	-13.33%
Dec 31, 2022	15	-1	-6.25%
Dec 31, 2021	16	4	33.33%
Dec 31, 2020	12	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	94,300
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

CING News

10 days ago - Stonegate Capital Partners Initiates Coverage on Cingulate Inc. (CING) - Newsfile Corp
7 weeks ago - Cingulate Inc. Reports First Quarter 2025 Financial Results and Provides an Updated Timeline of Key Developments for its lead ADHD and Anxiety Assets - GlobeNewsWire
2 months ago - Cingulate Receives $3 Million Grant from Private Foundation to Accelerate Development of Anxiety Asset CTx-2103 (buspirone) - GlobeNewsWire
3 months ago - Cingulate Inc. Reports Full Year 2024, Fourth Quarter Results, and Provides Development Update on Major Milestones Achieved - GlobeNewsWire
6 months ago - Cingulate Completes Financing Transaction for Net Proceeds of $5,000,000 - GlobeNewsWire
8 months ago - Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market - GlobeNewsWire
9 months ago - Cingulate's Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show - GlobeNewsWire
10 months ago - Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301 - GlobeNewsWire